[EN] SUBSTITUTED N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS [FR] N-CYANOPYRROLIDINES SUBSTITUÉES AYANT UNE ACTIVITÉ EN TANT QU'INHIBITEURS DE L'USP30
摘要:
The present invention relates to a class of substituted N-cyanopyrrolidines with activity as inhibitors of the deubiquitylating enzyme USP30, having utility in a variety of therapeutic areas, including conditions involving mitochondrial dysfunction, cancer and fibrosis: Formula (I).
[EN] SUBSTITUTED N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS [FR] N-CYANOPYRROLIDINES SUBSTITUÉES AYANT UNE ACTIVITÉ EN TANT QU'INHIBITEURS DE L'USP30
摘要:
The present invention relates to a class of substituted N-cyanopyrrolidines with activity as inhibitors of the deubiquitylating enzyme USP30, having utility in a variety of therapeutic areas, including conditions involving mitochondrial dysfunction, cancer and fibrosis: Formula (I).
[EN] SUBSTITUTED N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS<br/>[FR] N-CYANOPYRROLIDINES SUBSTITUÉES AYANT UNE ACTIVITÉ EN TANT QU'INHIBITEURS DE L'USP30
申请人:[en]MISSION THERAPEUTICS LIMITED
公开号:WO2023099561A1
公开(公告)日:2023-06-08
The present invention relates to a class of substituted N-cyanopyrrolidines with activity as inhibitors of the deubiquitylating enzyme USP30, having utility in a variety of therapeutic areas, including conditions involving mitochondrial dysfunction, cancer and fibrosis: Formula (I).